临床外科杂志
臨床外科雜誌
림상외과잡지
JOURNAL OF CLINICAL SURGERY
2014年
12期
910-913
,共4页
南润玲%尚培中%朱习琴%吉玉洁
南潤玲%尚培中%硃習琴%吉玉潔
남윤령%상배중%주습금%길옥길
乳腺浸润性导管癌%BRCA1%Ki-67%p53%免疫组化
乳腺浸潤性導管癌%BRCA1%Ki-67%p53%免疫組化
유선침윤성도관암%BRCA1%Ki-67%p53%면역조화
invasiveductalcarcinoma%breastcancersusceptibilitygene1protein%Ki-67%p53%immunohistochemistry
目的:观察乳腺浸润性导管癌组织中BRCA1、Ki-67及p53的表达及其与临床病理特征之间的关系。方法采用EliVisionTMplus两步免疫组化方法,检测BRCA1、Ki-67及P53在60例乳腺浸润性导管癌组织的表达情况。结果①60例乳腺浸润性导管癌组织中,BRCA1的阳性率为60.0%(36/60),Ki-67及 p53的阳性率分别为56.67%(34/60)、48.33%(29/60);②BRCA1蛋白表达与患者发病年龄、临床分期、伴有腋淋巴结转移以及组织学分级有关(P<0.05),而与肿瘤大小无关(P>0.05);Ki-67表达与临床分期、淋巴结转移、组织学分级有关(P<0.05),与发病年龄、肿瘤大小无关(P>0.05);p53表达与肿瘤大小、临床分期、淋巴结转移、组织学分级相关(P<0.05),与发病年龄无关(P>0.05);③BRCA1表达与 Ki-67、p53均呈负相关(r1=-0.577,P<0.05,r2=-0.504,P <0.05),Ki-67与p53的表达呈正相关(r =0.375,P<0.05)。结论联合检测BRCA1、Ki-67及p53对乳腺癌的早期诊断、恶性程度判定和预后监测有重要意义,可为乳腺癌的个体化治疗提供有效的指针。
目的:觀察乳腺浸潤性導管癌組織中BRCA1、Ki-67及p53的錶達及其與臨床病理特徵之間的關繫。方法採用EliVisionTMplus兩步免疫組化方法,檢測BRCA1、Ki-67及P53在60例乳腺浸潤性導管癌組織的錶達情況。結果①60例乳腺浸潤性導管癌組織中,BRCA1的暘性率為60.0%(36/60),Ki-67及 p53的暘性率分彆為56.67%(34/60)、48.33%(29/60);②BRCA1蛋白錶達與患者髮病年齡、臨床分期、伴有腋淋巴結轉移以及組織學分級有關(P<0.05),而與腫瘤大小無關(P>0.05);Ki-67錶達與臨床分期、淋巴結轉移、組織學分級有關(P<0.05),與髮病年齡、腫瘤大小無關(P>0.05);p53錶達與腫瘤大小、臨床分期、淋巴結轉移、組織學分級相關(P<0.05),與髮病年齡無關(P>0.05);③BRCA1錶達與 Ki-67、p53均呈負相關(r1=-0.577,P<0.05,r2=-0.504,P <0.05),Ki-67與p53的錶達呈正相關(r =0.375,P<0.05)。結論聯閤檢測BRCA1、Ki-67及p53對乳腺癌的早期診斷、噁性程度判定和預後鑑測有重要意義,可為乳腺癌的箇體化治療提供有效的指針。
목적:관찰유선침윤성도관암조직중BRCA1、Ki-67급p53적표체급기여림상병리특정지간적관계。방법채용EliVisionTMplus량보면역조화방법,검측BRCA1、Ki-67급P53재60례유선침윤성도관암조직적표체정황。결과①60례유선침윤성도관암조직중,BRCA1적양성솔위60.0%(36/60),Ki-67급 p53적양성솔분별위56.67%(34/60)、48.33%(29/60);②BRCA1단백표체여환자발병년령、림상분기、반유액림파결전이이급조직학분급유관(P<0.05),이여종류대소무관(P>0.05);Ki-67표체여림상분기、림파결전이、조직학분급유관(P<0.05),여발병년령、종류대소무관(P>0.05);p53표체여종류대소、림상분기、림파결전이、조직학분급상관(P<0.05),여발병년령무관(P>0.05);③BRCA1표체여 Ki-67、p53균정부상관(r1=-0.577,P<0.05,r2=-0.504,P <0.05),Ki-67여p53적표체정정상관(r =0.375,P<0.05)。결론연합검측BRCA1、Ki-67급p53대유선암적조기진단、악성정도판정화예후감측유중요의의,가위유선암적개체화치료제공유효적지침。
Objective ToinvestigatetheexpressionsofBRCA1,Ki-67andp53proteinininva-siveductalcarcinomaanddiscusstheircorrelationswithclinicopathologicalfeatures.Methods Theex-pressions of BRCA1,Ki-67and p53 were detected by immunohistochemistry with EliVisionTMplus two-step methodin60samplesofinvasiveductalcarcinomatissue.Results ThepositiverateofBRCA1protein was 60.0%(36/60).The positive rates of Ki-67 and p53 were 56.67%(34/60)and 48.33%(29/60). The expression of BRCA1 protein was related to the age of onset,clinical stage,lymph node metastasis and histological grade(P<0.05),but not associated with tumor size(P>0.05).The expression of Ki-67 was related to the clinical stage,lymph node metastasis and histological grade(P<0.05),but not associated with the age of onset or tumor size(P>0.05).The expression of p53 was related to the age of onset,clini-cal stage,lymph node metastasis and histological grade(P<0.05),but not associated with tumor size(P>0.05).The expression of BRCA1 protein in invasive ductal carcinoma was negatively correlated with Ki-67 and p53(r1 =-0.577,P<0.05,r2 =-0.504,P<0.05).The expression of Ki-67 was positively corre-latedwithp53(r=0.375,P<0.05).Conclusion CombineddetectionofBRCA1,Ki-67andp53isof important significance in early diagnosis,malignancy judgment and prognosis monitoring for invasive ductal carcinoma,which can provide effective indexes for individualized therapies.